Hospital costs of immunopreventable diseases in the economically active population in Brazil

Abstract Background Immunopreventable diseases are a public health reality in Brazil and worldwide, a reality that is not exclusive to children, but affects the adult population. Objectives Discriminating the total costs of hospitalizations from immunopreventable diseases in the population aged 20 t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Élide Sbardellotto M. da Costa, Adriano Hyeda, Eliane M. C. P. Maluf
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Employment Communicable diseases Vaccines Unified health system Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/b5f4c9218ed9425a895f830d7e5de8a5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b5f4c9218ed9425a895f830d7e5de8a5
record_format	dspace
spelling	oai:doaj.org-article:b5f4c9218ed9425a895f830d7e5de8a52021-11-14T12:09:54ZHospital costs of immunopreventable diseases in the economically active population in Brazil10.1186/s12913-021-07029-41472-6963https://doaj.org/article/b5f4c9218ed9425a895f830d7e5de8a52021-11-01T00:00:00Zhttps://doi.org/10.1186/s12913-021-07029-4https://doaj.org/toc/1472-6963Abstract Background Immunopreventable diseases are a public health reality in Brazil and worldwide, a reality that is not exclusive to children, but affects the adult population. Objectives Discriminating the total costs of hospitalizations from immunopreventable diseases in the population aged 20 to 59 years. Methods A population, observational, descriptive, retrospective study was conducted with secondary information from DATASUS to discriminate the hospitalizations associated with immunopreventable diseases in Brazil and their care costs, within the Scope of the SUS, between 2008 and 2018, in the economically active population (20 to 59 years). Results It was analyzed 127,746 hospitalizations for immunopreventable diseases, (27.92% of all hospitalizations) were observed in the adult population, totaled R$115,682,097.54 (29.72% of the total costs). Of this population studied, 51.48% were registered as male; 66.74% were associated with influenza disease; 16.05% to chickenpox/herpes zoster infection and 7.55% to acute hepatitis B infections. The trend analysis of the time series of hospitalizations in this population showed a stationary trend. Conclusions The 127,746 hospitalizations could be avoided with immunization, and 127,746 workers who could be working and not hospitalized. There were also R$115,682,097.54 that could be invested in other public health needs, which became necessary for the treatment of preventable diseases.Élide Sbardellotto M. da CostaAdriano HyedaEliane M. C. P. MalufBMCarticleEmploymentCommunicable diseasesVaccinesUnified health systemPublic aspects of medicineRA1-1270ENBMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Employment Communicable diseases Vaccines Unified health system Public aspects of medicine RA1-1270
spellingShingle	Employment Communicable diseases Vaccines Unified health system Public aspects of medicine RA1-1270 Élide Sbardellotto M. da Costa Adriano Hyeda Eliane M. C. P. Maluf Hospital costs of immunopreventable diseases in the economically active population in Brazil
description	Abstract Background Immunopreventable diseases are a public health reality in Brazil and worldwide, a reality that is not exclusive to children, but affects the adult population. Objectives Discriminating the total costs of hospitalizations from immunopreventable diseases in the population aged 20 to 59 years. Methods A population, observational, descriptive, retrospective study was conducted with secondary information from DATASUS to discriminate the hospitalizations associated with immunopreventable diseases in Brazil and their care costs, within the Scope of the SUS, between 2008 and 2018, in the economically active population (20 to 59 years). Results It was analyzed 127,746 hospitalizations for immunopreventable diseases, (27.92% of all hospitalizations) were observed in the adult population, totaled R$115,682,097.54 (29.72% of the total costs). Of this population studied, 51.48% were registered as male; 66.74% were associated with influenza disease; 16.05% to chickenpox/herpes zoster infection and 7.55% to acute hepatitis B infections. The trend analysis of the time series of hospitalizations in this population showed a stationary trend. Conclusions The 127,746 hospitalizations could be avoided with immunization, and 127,746 workers who could be working and not hospitalized. There were also R$115,682,097.54 that could be invested in other public health needs, which became necessary for the treatment of preventable diseases.
format	article
author	Élide Sbardellotto M. da Costa Adriano Hyeda Eliane M. C. P. Maluf
author_facet	Élide Sbardellotto M. da Costa Adriano Hyeda Eliane M. C. P. Maluf
author_sort	Élide Sbardellotto M. da Costa
title	Hospital costs of immunopreventable diseases in the economically active population in Brazil
title_short	Hospital costs of immunopreventable diseases in the economically active population in Brazil
title_full	Hospital costs of immunopreventable diseases in the economically active population in Brazil
title_fullStr	Hospital costs of immunopreventable diseases in the economically active population in Brazil
title_full_unstemmed	Hospital costs of immunopreventable diseases in the economically active population in Brazil
title_sort	hospital costs of immunopreventable diseases in the economically active population in brazil
publisher	BMC
publishDate	2021
url	https://doaj.org/article/b5f4c9218ed9425a895f830d7e5de8a5
work_keys_str_mv	AT elidesbardellottomdacosta hospitalcostsofimmunopreventablediseasesintheeconomicallyactivepopulationinbrazil AT adrianohyeda hospitalcostsofimmunopreventablediseasesintheeconomicallyactivepopulationinbrazil AT elianemcpmaluf hospitalcostsofimmunopreventablediseasesintheeconomicallyactivepopulationinbrazil
_version_	1718429426945884160

Hospital costs of immunopreventable diseases in the economically active population in Brazil

Ejemplares similares